Answers are grounded in this paper and cite their sources.
Integration of diagnostic biomarkers enhances specificity in identifying multiple sclerosis without losing sensitivity.
Integrating CVS and PRL represents potentially advantageous MS diagnostic biomarkers, with increased specificity and without substantial reduction in sensitivity.
No takes yet. Share an insight, caveat, or question.
Toljan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: